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Abstract
Purpose Black extrinsic discoloration is a common clinical and aesthetic problem. This study aims to evaluate the potential 
in vitro antagonistic activity of two commercial probiotics, Streptococcus salivarius M18 and Lactobacillus reuteri ProDentis, 
against microorganisms associated with black stains.
Methods Streptococcus salivarius M18 and Lactobacillus reuteri were tested against Aggregatibacter actinomycetemcomitans 
and Actinomyces naeslundiiusing their cell-free fermentative broth in a planktonic growth inhibition test.
Results Both probiotic cell-free supernatants showed the ability to reduce the pathogenic bacteria growth in a dose-dependent 
way. Streptococcus salivarius M18 showed a stronger antimicrobial activity than Lactobacillus reuteri ProDentis against 
the two indicator strains used. A. naeslundi was less susceptible to the probiotic activity of both S. salivarius and L. reuteri 
compared to A. actinomycetemcomitans.
Conclusions The obtained results demonstrate a potent antagonistic ability of probiotics to reduce the growth of 
microorganisms associated with black tooth stains. Therefore, these strains could be evaluated for a therapeutic use against 
dental pigmentations.
Keywords Aggregatibacter actinomycetemcomitans · Actinomyces naeslundii · Streptococcus salivarius M18 · 
Lactobacillus reuteri · Black stain
Introduction
Black extrinsic discoloration is a common clinical and 
aesthetic problem in childhood. Both primary and permanent 
teeth can be affected, with a reported prevalence of 1–20% 
(Ronay and Attin 2011). Black stain (BS) is considered a 
special form of dental plaque unique for its insoluble iron 
salts and high calcium and phosphate contents (Hattab 
et al. 1999; Reid and Beeley 1976). Previous culture-based 
studies have indicated an association between black tooth 
stain and chromogenic bacteria. While at first periodontal 
bacteria, such as Porphyromonas gingivalis, Prevotella 
intermedia and Prevotella melaninogenica were reported to 
be closely related to BS (Soukos et al. 2005), traditional and 
molecular examinations have proposed Actinomycetes as 
an etiological factor in the production of black pigment. 
Specifically, Aggregatibacter actinomycetemcomitans and 
Actinomyces  naeslundii are reported as significantly 
predominant cultivable microorganisms found in patients 
with BSs (Saba et al. 2006; Li et al. 2015; Heinrich-Weltzien 
et al. 2014).
Current treatments focus on mechanical removal of the 
stains, which are hard to be removed by daily tooth brushing 
and are prone to resurface after professional scaling (Hattab 
et al. 1999). Therefore, further research on prevention and 
therapy of BSs is needed.
Probiotic bacteria are live microbial food supplements 
that confer a health benefit on humans (de Vrese and 
Schrezenmeir 2008). Their use to effect an improvement in 
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oral health is a relatively undeveloped strategy and it has 
been investigated for prevention and treatment of dental 
caries, periodontal disease and for halitosis (Meurman 2005; 
Twetman and Stecksén-Blicks 2008; Allaker and Stephen 
2017; Teughels et al. 2011).
To the best of our knowledge, no report on the 
introduction of beneficial bacterial population to help 
counter the proliferation of chromogenic species can be 
found in the published literature so far. Generally, probiotic 
activity is considered to influence the balance among the 
many species of commensal flora in the oral cavity. It is our 
view that probiotics may have beneficial applications in the 
reduction of BSs by inhibiting the proliferation of the BS 
associated bacteria, as demonstrated in vivo in a clinical 
trial (Bardellini et al. 2020), still the reasons why a probiotic 
intake inhibits the formation of BS requires further studies.
Among probiotics, Streptococcus salivarius possesses 
excellent credentials as an oral probiotic (Tagg and Dierksen 
2003; Burton et al. 2011). It is a pioneer colonizer of the 
human oral cavity and produces bacteriocins, ribosomally 
synthesized proteinaceous antibiotics typically encoded 
by megaplasmid-borne loci (Wescombe et al. 2006). More 
specifically, the strain S. salivarius M18 has been shown 
to colonize and persist in the human oral cavity (Burton, 
Wescombe et al. 2013b), to reduce plaque formation (Burton 
and Drummond et  al. 2013a) and to reduce gingivitis 
and periodontitis (Litty et  al. 2015) Another probiotic 
is Lactobacillus reuteri, an obligate heterofermentative 
resident in the gastrointestinal tract in humans (Itsaranuwat 
et  al. 2003) which is reported to produce antimicrobial 
substances with a broad-spectrum activity (Talarico 
et al. 1988; Ganzle et al. 2000), and it is effective against 
Streptococcus mutans (Caglar et al. 2008), as well as against 
periodontal pathogens (Vivekananda et al. 2010; Vicario 
et al. 2013).
To be able to display a probiotic effect against BSs 
a bacterium must compete with chromogenic bacteria, 
thus reducing the level of their colonization. The purpose 
of this study was to evaluate the inhibitory effects of 
two commercially available probiotics Streptococcus 
salivarius M18 and Lactobacillus reuteri Prodentis on 
growth inhibition of chromogenic bacteria, specifically A. 
actinomycetemcomitans and A. naeslundii, using their cell-




Streptococcus salivarius M18 (IDA classification: DSM 
14,865), also named by the manufacturer as BLIS M18 
(BLIS Technologies, Dunedin, New Zealand), distributed 
as  Carioblis® by Omeopiacenza (Pontenure, Italy), and 
Lactobacillus reuteri (1 × 108 CFU) strains DSM17938 
and ATCC PTA5289 (Prodentis; BioGaia, Lund, Sweden) 
were used as probiotic strains. Two types of oral bacteria 
were used to test the antibacterial effect of these probiotic 
strains: Aggregatibacter actinomycetemcomitans DSM-
13386 (DSMZ, Braunschweig, Germany) and Actinomyces 
naeslundii DSM-11123 (DSMZ, Braunschweig, Germany). 
They were cultured using Schaedler agar with vitamin K 
and 5% Sheep Blood (BD bioscience, Sparks, MD, USA) in 
anaerobic conditions.
Antimicrobial activity of S. salivarius and L. reuteri 
against oral bacteria
Bacterial strains were stored in tryptic soy broth (TSB) 
medium with 20% of glycerol at − 80  °C and used as 
required. Bacterial isolates (Streptococcus salivarius 
and Lactobacillus reuteri) from frozen stock were grown 
overnight and 500 μl was then subcultured in brain heart 
infusion (BHI) medium (BD bioscience, Sparks, MD, USA) 
for 48 h at 37 °C in anaerobic conditions. The bacterial 
suspensions were centrifuged at 4 °C for 10 min at 12.000xg 
and sterilized by filtration trough a 0.22 mm Millipore filter 
(Merck Millipore, Milano, Italy).
A test of the antibacterial properties of this medium was 
performed in accordance with recommendations from the 
Clinical and Laboratory Standards Institute (CLSI) (2012, 
2016). A serial dilution was performed starting with 180 μl 
of cell-free supernatants (CFS) of S. salivarius and L. reuteri 
in BHI medium to reach a proportion range of 10–90%.
A. actinomycetemcomitans and A. naeslundii culture 
suspensions were diluted using fresh sterile BHI medium, 
so that the turbidity was equal to that of a McFarland 0.5 
standard. Afterwards, 20 μl of each bacterial suspension 
was inoculated in each well of a 96-well plate up to a final 
volume of 200  μl. BHI medium without inoculum and 
BHI medium with only the indicator bacteria were used as 
negative and positive control, respectively. The plate was 
then incubated for 24 h at 37 °C in an anaerobic chamber. 
Bacterial growth was measured at a wavelength of 600 nm 
using a microplate spectrometer. The entire experiment was 
performed three times with three independent repetitions.
Statistical analysis
The primary outcome of this study was the bacterial growth 
mean of A. actinomycetemcomitans and A. naeslundii 
culture suspensions evaluated when grown separately in 
BHI (controls) and in BHI added with different dilutions of 
CFS of S. salivarius or L. reuteri. Two hierarchical models 
were built, one for each culture, to estimate bacterial growth 
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(measured 3 times per dilution, from 10 to 90%) in relation 
to dilution (from 10 to 90%) and “CASES” (control, CFS 
of S. salivarius, CFS of L. reuteri). Because normality 
assumptions were rejected, logarithm transformation was 
performed and estimates were than back-transformed to 
the original unit of measurement. Results are reported as 
estimates and 95% confidence intervals. All analyses were 
performed assuming a significance level of 5% using the 
statistical software R (version 3.4.2).
Results
Antibacterial activity of Streptococcus salivarius M18 
and Lactobacillus reuteri
The effect of the two probiotics on the chromogenic 
actinomycetes’ growth was explored by adding increasing 
concentration of single CFS of the 48-h-old probiotic 
cultures to the culture medium of the actinomycetes.
Anti-A. actinomycetemcomitans activity of S. salivarius 
M18 occurred drastically at CFS concentrations of 40% 
and higher (Fig. 1a) with a significant reduction of the A. 
actinomycetemcomitans’ growth (p value = 0.001) and a 
complete growth inhibition at 90%. Differently, anti-A. 
actinomycetemcomitans activity of L. reuteri occurred 
at CFS concentrations higher than 60% (p value = 0.001) 
(Fig. 1a).
Anti-A. naeslundii activity of S. salivarius M18 occurred 
at concentrations higher than 40% with a complete growth 
inhibition at 90% (Fig. 1b), while anti-A. naeslundii activity 
of L. reuteri occurred at a concentration of 80% without 
reaching a complete growth inhibition at 90% (Fig. 1b). Both 
S. salivarius M18 and L. reuteri significantly reduced the 
A. naeslundii growth ranging between the concentrations 
of 40% (p value < 0.040) and of 70% (p value < 0.0001), 
respectively.
Discussion
BSs are characteristic pigmented deposits that may occur 
at any age but seem to peak in childhood with a decrease in 
prevalence during pubescence and adulthood. Even if not 
Fig. 1  Antibacterial activity of Streptococcus salivarius M18 
and Lactobacillus reuteri ProDentis against Aggregatibacter 
actinomycetemcomitans (a) and Actinomyces naeslundii (b). CFS, 
cell-free supernatant. Each point represents the mean of three 
determinations (n = 9, average + 95% confidence interval). Asterisks 
are used to denote relevant comparisons and statistical significance as 
follows: *p = 0.001, **p = 0.0002, ***p ≤ 0.0001
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correlated with caries, BS represents an aesthetic problem, 
especially in the parents’ eyes.
Probiotics are generally defined as microorganisms that 
confer a health benefit on humans by establishing a balance 
between beneficial and pathogenic bacteria (Koll et al. 2008; 
Li et al. 2015; Krasse et al. 2006). Their use is a relatively 
undeveloped strategy for prevention and treatment of caries 
and periodontitis (de Vrese and Schrezenmeir 2008).
BSs too are associated with a segregation of microbial 
communities in the oral cavity (Krasse et al. 2006), thus this 
approach has been considered as potentially beneficial in the 
prevention and treatment of BSs and applied for the first time 
in a clinical trial (Bardellini et al. 2020).
This short note is a preliminary contribution to unravel 
the underlying mechanisms. The study was undertaken to 
compare the in vitro efficiencies of two commercial probiotic 
products, including that used in the above mentioned clinical 
trial, against planktonic oral actinomycetes which are 
commonly reported as associated to BSs.
Both probiotics show antagonistic capacity, as their 
fermentative broth was able to significantly reduce the 
growth of the tested bacterial strains. Notably, in this 
study Streptococcus salivarius M18 showed a stronger 
antimicrobial activity than Lactobacillus reuteri ProDentis 
against the two indicator strains used. Furthermore, 
this study shows that A. naeslundi is less susceptible to 
the probiotic activity of both S. salivarius and L. reuteri 
compared to A. actinomycetemcomitans, whose growth 
is completely inhibited at high cell-free fermentative 
broth concentrations. This study also indicates a dose-
dependent inhibiting activity of the two probiotics as higher 
the concentrations of their fermentative broth used in the 
experiments, the higher was the reduction of the bacterial 
indicators growth.
The activities of S. salivarius and L. reuteri against 
these actinomycetes have already been reported, although 
strains and culture media may differ and generally the 
pathogenic bacteria were in association to periodontal 
diseases (Teughels et al. 2013; Kang et al. 2011; Twetman 
et al. 2009).
The nature of the antimicrobial activity exerted by the 
two probiotics in this work remains unclear. Because in 
this study, pH evaluation of CFS was not performed, the 
presented data do not support whether the inhibition is 
due to some secreted metabolite, present in the cell-free 
supernatants of S. salivarius and L. reuteri or due to organic 
acids production, which could contribute to reducing the 
number of indicator bacteria. However, some previous 
studies demonstrated that the acidic environment provided 
by Lactobacillus strains can directly affect their antibacterial 
activities against S. mutans (Lin et al. 2015; Keller et al. 
2011). Therefore, the role of the acids produced by probiotic 
strains on bacterial growth is still unclear.
This is corroborated by many reports showing that 
Lactobacilli can produce organic acids,  H2O2 and 
bacteriocins (Cintas et al. 2001) while S. salivarius M18 
releases into saliva copious quantities of bacteriocins and 
enzymes as dextranase and urease (Heng et  al. 2011). 
Additional research is required to verify the mechanism of 
antibacterial activity found here and if and which probiotic 
metabolites are eventually produced in vitro and in vivo 
during the interactions studied in this work and what is their 
role in the oral cavity for preventing BSs.
This study ascertained in vitro the potential antagonistic 
activity of two commercial products, Streptococcus 
salivarius M18 and Lactobacillus reuteri ProDentis: these 
strains are to be considered for a therapeutic use against 
dental pigmentations.
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